An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies. - Individual Prediction and Prevention of Risks of Immunosuppressive Therapies in Transplantation Access content directly
Journal Articles PLoS ONE Year : 2017

An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies.

Abstract

Most predictive models and scores of graft survival in renal transplantation include factors known before transplant or at the end of the first year. They cannot be updated thereafter, even in patients developing donor-specific anti-HLA antibodies and acute rejection.We developed a conditional and adjustable score for prediction of graft failure (AdGFS) up to 10 years post-transplantation in 664 kidney transplant patients. AdGFS was externally validated and calibrated in 896 kidney transplant patients.The final model included five baseline factors (pretransplant non donor-specific anti-HLA antibodies, donor age, serum creatinine measured at 1 year, longitudinal serum creatinine clusters during the first year, proteinuria measured at 1 year), and two predictors updated over time (de novo donor-specific anti-HLA antibodies and first acute rejection). AdGFS was able to stratify patients into four risk-groups, at different post-transplantation times. It showed good discrimination (time-dependent ROC curve at ten years: 0.83 (CI95% 0.76-0.89).
Fichier principal
Vignette du fichier
journal.pone.0180236.pdf (4.76 Mo) Télécharger le fichier
S1_Fig.pdf (35.35 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

inserm-01547862 , version 1 (27-06-2017)

Identifiers

Cite

Aurélie Prémaud, Matthieu Filloux, Philippe Gatault, Antoine Thierry, Matthias Buchler, et al.. An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies.. PLoS ONE, 2017, 12 (7), pp.e0180236. ⟨10.1371/journal.pone.0180236⟩. ⟨inserm-01547862⟩
282 View
214 Download

Altmetric

Share

Gmail Facebook X LinkedIn More